If your email client cannot read HTML emails, please visit our website

IMPORTANT E-MAIL DELIVERY INFORMATION: In order to view our newsletters in their entirety, please add our email address, news@johnshopkins.6cp.com, to your Contact List, Safe List or Address Book. This action should also ensure eViralHepatitis Review emails go directly to your Inbox.

Please do not reply to this email. To change/update your email address, please visit here.

Unsubscribe from this list.
Download PDF
eViralHepatitis Review eViralHepatitis Review
HOME NEWSLETTER
ARCHIVE
CME
INFORMATION
PROGRAM
DIRECTORS
EDIT
PROFILE
RECOMMEND TO
A COLLEAGUE

 

 

VOLUME 5 - ISSUE 8

LISTEN TO PODCAST

DOWNLOAD PODCAST

 

 

POST TEST

POST TEST

 

 

Using Real World Data to Individualize HCV Management

 

Editor's Note: ´╗┐Since the recording, glecaprevir/pibrentasvir has been FDA approved.

After participating in this activity, the participant will demonstrate the ability to:
 
  • Discuss the real-world data to support a sofosbuvir-ledipasvir treatment duration of 8 weeks versus 12 weeks.
  • Summarize the current hepatitis C treatment options for patients with advanced kidney disease.
  • Describe the risks and benefits of hepatitis C therapies in HIV-HCV coinfected patients. 

Guest Faculty Disclosure
Dr. Muir has disclosed that he has served as a consultant and/or advisor to AbbVie, Inc. Gilead Sciences, Inc., and Merck & Co., Inc. He has also received grant and/or research funding from AbbVie, Inc., Gilead Sciences, Inc., and Merck & Co., Inc. 

Unlabeled/Unapproved Uses
He has indicated that there will be no references to the unlabeled or unapproved use of any drugs or products in today’s discussion.

 

MEET THE AUTHOR

 

 

 

 

Andrew Joseph Muir, MD
Professor of Medicine
Chief, Division of Gastroenterology
Duke University School of Medicine
Durham, North Carolina

 

 


Release Date: Expiration Date:
September 28, 2017 September 27, 2019

 

 

 

 

OTHER RESOURCES

 

 

 

Download the podcast transcript

Go to the companion newsletter

 

 

 

 


PROGRAM DIRECTORS

Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and
Gastroenterology/Hepatology

Johns Hopkins University School of Medicine
Baltimore, Maryland

Raymond T. Chung, MD
Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar

Massachusetts General Hospital
Harvard Medical School

Boston, Massachusetts

Taryn Haselhuhn, BA, BSN, MSN, CRNP
Nurse Practitioner
Johns Hopkins Hospital
Baltimore, Maryland

 

 

 

 

CME/CE INFORMATION

 

 

ACCREDITATION STATEMENT
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Nurses
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

CREDIT DESIGNATION STATEMENT
Physicians
eNewsletter: The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
eNewsletter: This 1.0 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 0.5 contact hour, or a total of 3 contact hours for the 6 newsletters in this program. 

POLICY ON SPEAKER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the instructional materials.

 

INTERNET CME/CE POLICY

DISCLAIMER STATEMENT

STATEMENT OF RESPONSIBILITY

STATEMENT OF NEED
INTENDED AUDIENCE

CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANTS

HARDWARE & SOFTWARE REQUIREMENTS

COMPLETE CME INFORMATION

 

 

 

All rights reserved - The Johns Hopkins University School of Medicine. Copyright 2017.

This activity was developed in collaboration with DKBmed.